膀癌的三模式疗法:单一机构对高风险患者接受器官节约疗法的结果相关因素的回顾性分析
Monica S Nair1, Jessica Scarborough2, Chandana A Reddy2
1Cleveland Clinic Lerner College of Medicine, Case Western University School of Medicine, Cleveland, OH; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Clinical genitourinary cancer
|December 25, 2025
概括
囊切除术的资格与接受三模式治疗的膀癌患者的更好的生存率有关. 多学科评估对于选择候选人进行膀保护治疗至关重要.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 三种疗法 (TMT) 为高风险的非肌肉侵入性和肌肉侵入性膀癌 (MIBC) 提供膀保护.
- 确定影响TMT结果的因素对于优化患者护理至关重要.
- 患者和疾病特征显著影响TMT后的存活率.
研究的目的:
- 定义患者和疾病特征,与高风险膀癌TMT后的结果相关.
- 确定预测膀保护疗法治疗患者的存活率的因素.
- 分析大量MIBC队列中的生存率,癌症特异性死亡率和局部复发率.
主要方法:
- 在2006-2022年期间接受治疗的226名高风险非MIBC或MIBC患者的回顾性分析.
- 卡普兰-梅尔和累积发病率分析的生存率和复发率.
- 考克斯比例危险和竞争风险回归模型,以确定预后因素.
主要成果:
- 在多变量分析中,较年轻的年龄和囊切除资格与改善的整体存活率 (OS) 独立相关.
- 单变量分析还显示,新辅助化疗 (NAC) 与改善的生存状况有关.
- 随访时间中位数为18.9个月,该队列的平均年龄为79岁.
结论:
- 囊切除术的资格是治疗TMT的MIBC患者生存率改善的重要预测因素.
- 多学科评估对于确定器官保护疗法的候选人至关重要.
- 这些发现强调了全面评估对于膀癌治疗选择的重要性.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...